Literature DB >> 16299327

Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells.

Raquel Garcia-Medina1, W Michael Dunne, Pradeep K Singh, Steven L Brody.   

Abstract

Pseudomonas aeruginosa can notably cause both acute and chronic infection. While several virulence factors are implicated in the acute phase of infection, advances in understanding bacterial pathogenesis suggest that chronic P. aeruginosa infection is related to biofilm formation. However, the relationship between these two forms of disease is not well understood. Accumulating evidence indicates that, during acute infection, P. aeruginosa enters epithelial cells, a process viewed as either a host-mediated defense response or a pathogenic mechanism to avoid host-mediated killing. We investigated the possibility that epithelial cell entry during early P. aeruginosa-epithelial cell contact favors bacterial survival and is linked to chronic infection. Using electron microscopy and confocal microscopy to analyze primary culture airway epithelial cells infected with P. aeruginosa, we found that epithelial cells developed pod-like clusters of intracellular bacteria with regional variation in protein expression. Extracellular gentamicin added to the medium after acute infection led to the persistence of intracellular P. aeruginosa for at least 3 days. Importantly, compared to bacterial culture under planktonic conditions, the intracellular bacteria were insensitive to growth inhibition or killing by antibiotics that were capable of intraepithelial cell penetration. These findings suggest that P. aeruginosa can use airway epithelial cells as a sanctuary for persistence and develop a reversible antibiotic resistance phenotype characteristic of biofilm physiology that can contribute to development of chronic infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299327      PMCID: PMC1307054          DOI: 10.1128/IAI.73.12.8298-8305.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose.

Authors:  M C Birmingham; R Guarino; A Heller; J H Wilton; A Shah; L Hejmanowski; D E Nix; J J Schentag
Journal:  J Antimicrob Chemother       Date:  1999-03       Impact factor: 5.790

2.  Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells.

Authors:  M E Cavet; M West; N L Simmons
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

3.  Pulmonary penetration of ceftazidime.

Authors:  M Cazzola; M Gabriella Matera; M Polverino; G Santangelo; I De Franchis; F Rossi
Journal:  J Chemother       Date:  1995-02       Impact factor: 1.714

4.  Measurement of invasion by gentamicin resistance.

Authors:  E A Elsinghorst
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

5.  Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease.

Authors:  L V Möller; W Timens; W van der Bij; K Kooi; B de Wever; J Dankert; L van Alphen
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

6.  Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa.

Authors:  S M Fleiszig; T S Zaidi; M J Preston; M Grout; D J Evans; G B Pier
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  The involvement of cell-to-cell signals in the development of a bacterial biofilm.

Authors:  D G Davies; M R Parsek; J P Pearson; B H Iglewski; J W Costerton; E P Greenberg
Journal:  Science       Date:  1998-04-10       Impact factor: 47.728

8.  Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of twitching motility.

Authors:  A Glessner; R S Smith; B H Iglewski; J B Robinson
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

9.  Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection.

Authors:  M Feldman; R Bryan; S Rajan; L Scheffler; S Brunnert; H Tang; A Prince
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

10.  Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development.

Authors:  G A O'Toole; R Kolter
Journal:  Mol Microbiol       Date:  1998-10       Impact factor: 3.501

View more
  51 in total

1.  Elevated inflammatory response in caveolin-1-deficient mice with Pseudomonas aeruginosa infection is mediated by STAT3 protein and nuclear factor kappaB (NF-kappaB).

Authors:  Kefei Yuan; Canhua Huang; John Fox; Madeleine Gaid; Andrew Weaver; Guoping Li; Brij B Singh; Hongwei Gao; Min Wu
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Optical Imaging of Bacterial Infection Models.

Authors:  W Matthew Leevy; Nathan Serazin; Bradley D Smith
Journal:  Drug Discov Today Dis Models       Date:  2007

3.  Involvement of stress-related genes polB and PA14_46880 in biofilm formation of Pseudomonas aeruginosa.

Authors:  Sahar A Alshalchi; Gregory G Anderson
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  When the resistance gets clingy: Pseudomonas aeruginosa harboring metallo-β-lactamase gene shows high ability to produce biofilm.

Authors:  L R R Perez; A L S Antunes; A L P Freitas; A L Barth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-04       Impact factor: 3.267

Review 5.  Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.

Authors:  Diana P Pires; Diana Vilas Boas; Sanna Sillankorva; Joana Azeredo
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 6.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

7.  Campylobacter jejuni biofilms up-regulated in the absence of the stringent response utilize a calcofluor white-reactive polysaccharide.

Authors:  Meghan K McLennan; Danielle D Ringoir; Emilisa Frirdich; Sarah L Svensson; Derek H Wells; Harold Jarrell; Christine M Szymanski; Erin C Gaynor
Journal:  J Bacteriol       Date:  2007-11-09       Impact factor: 3.490

8.  Polyphosphate kinase 1 is a pathogenesis determinant in Campylobacter jejuni.

Authors:  Heather L Candon; Brenda J Allan; Cresson D Fraley; Erin C Gaynor
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

9.  Counteracting signaling activities in lipid rafts associated with the invasion of lung epithelial cells by Pseudomonas aeruginosa.

Authors:  David W Zaas; Zachary D Swan; Bethany J Brown; Guojie Li; Scott H Randell; Simone Degan; Mary E Sunday; Jo Rae Wright; Soman N Abraham
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

10.  Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model.

Authors:  Rebecca M Green; Fabienne Gally; Jonathon G Keeney; Scott Alper; Bifeng Gao; Min Han; Richard J Martin; Andrew R Weinberger; Stephanie R Case; Maisha N Minor; Hong Wei Chu
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.